Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2007-07-10
2007-07-10
Campell, Bruce R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S199100, C424S233100, C424S093100, C424S093200, C435S093000
Reexamination Certificate
active
09684554
ABSTRACT:
The invention provides an isolated and purified DNA molecule comprising at least one DNA segment, a biologically active subunit or variant thereof, of a circular intermediate of adeno-associated virus, which DNA segment confers increased episomal stability, persistence or abundance of the isolated DNA molecule in a host cell. The invention also provides a composition comprising at least two adeno-associated virus vectors.
REFERENCES:
patent: 5604090 (1997-02-01), Alexander et al.
patent: 5691176 (1997-11-01), Lebkowski et al.
patent: 5831068 (1998-11-01), Nair et al.
patent: 5834182 (1998-11-01), Alexander et al.
patent: 6083702 (2000-07-01), Mitchell et al.
patent: 6200560 (2001-03-01), Couto et al.
patent: 6221349 (2001-04-01), Couto et al.
patent: 6436392 (2002-08-01), Engelhardt et al.
patent: 6544786 (2003-04-01), Xiao et al.
patent: 7060497 (2006-06-01), Nakai et al.
patent: 2002/0076754 (2002-06-01), Sun et al.
patent: 2002/0197237 (2002-12-01), Engelhardt et al.
patent: 2003/0103939 (2003-06-01), Engelhardt et al.
patent: 4091299 (1999-12-01), None
patent: 1153612 (2001-11-01), None
patent: 94/13788 (1992-12-01), None
patent: 95/07351 (1993-09-01), None
patent: 98/09657 (1996-09-01), None
patent: 97/22250 (1996-12-01), None
patent: 99/60146 (1998-05-01), None
patent: WO-98/24479 (1998-06-01), None
patent: WO-0125465 (2001-04-01), None
Rendahl et al. Regulation of gene expression in vivo following transduction by two seperate rAAV vectors. Nature Biotechnology (1998) vol. 16, pp. 757-761.
Doll RF, Gene Therapy vol. 3, pp. 437-447, 1996.
Capecchi M., Science, vol. 244, pp. 1288-1292.
Duan D., Molecular Therapy, vol. 4, No. 4, pp. 383-391, 2001.
Duan, D., et al., “Circular intermediates of recombinant adeno-associated virus having defined structural characteristics responsible for long-term episomal persistence in muscle tissue”,J. of Virology, 72 (11), pp. 8568-8577, (Nov. 1998).
Duan, D., et al., “Formation of adeno-associated virus circular genomes is differentially regulated by adenovirus E4 ORF6 and E2a gene expression”,J. Virology, 73 (1), pp. 161-169, (Jan. 1999).
Duan, D., et al., “Structural Analysis of adeno-associated virus transduction circular intermediates”,Virology, 261 (1), pp. 8-14, (Aug. 1999).
Duan, D., et al., “Structural and functional heterogeneity of intregrated recombinant AAV genomes”,Virus Research, 48 (1), pp. 41-56, (Jan. 1997).
Fisher, K., et al., “Recombinant adeno-associated virus for muscle directed gene therapy”,Nature Medicine, 3 (3), pp. 306-312, (Mar. 1997).
Giraud, C., et al., “Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome”,J. of Virology, 69 (11), pp. 6917-6924, (Nov. 1995).
Herzog, R.W., et al., “Stable gene transfer and expressionof human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus”,PNAS, 94, pp. 5804-5809, (May 1997).
Puttaraju, M., et al., “Spliceosome-mediated RNA trans-splicing as a tool for gene therapy”,Nature Biotechnology, 17 (3), pp. 246-252, (Mar. 1999).
Ramage, A.D., et al., “Improved EBV-based shuttle vector system: dicistronic mRNA couples the synthesis of the epstein-Barr nuclear antigen-1 protein toneomycin resistance”,Gene, 197 (102), pp. 83-89, (1997).
Xiao, X., et al., “Efficient long-term gene transfer into muscle tissue of immunocomponent mice by adeno-associated virus vector”,J. of Virology, 70 (11), pp. 8098-8108, (Nov. 1996).
Yan, Z., et al., “Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy”,PNAS, 97 (12), pp. 6716-6721, (Jun. 6, 2000).
Yang, J., et al., “Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination”,J. of Virology, 73 (11), pp. 9468-9477, (Nov. 1999).
Afione, S. A., et al., “In Vivo Model of Adeno-Associated Virus Vector Persistence and Rescue”,Journal of Virology, 70 (5), (May 1996),pp. 3235-3241.
Alexander, I E., et al., “DNA-Damaging Agents Greatly Increase the Transduction of Nondividing Cells by Adeno-Associated Virus Vectors”,Journal of Virology, 68 (12), (1994),pp. 8282-8287.
Alexander, I E., et al., “Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus Vectors”,Human Gene Therapy, 7, (1996),pp. 841-850.
Ali, R. R., et al., “Gene transfer into the mouse retina mediated by an adeno-associated viral vector”,Human Molecular Genetics, 5 (5), (1996),pp. 591-594.
Bennett, J. , et al., “Real-Time, Noninvasive In Vivo Assessment of Adeno-Associated Virus-Mediated Retinal Transduction”,Investigative Ophthalmology&Visual Science, 38 (13), (Dec. 1997),pp. 2857-2863.
Berns, K. I., et al., “Biology of Adeno-associated Virus”,In: Current Topics in Microbiology and Immunology, 218, Springer-Verlag, Berlin: R.W. Compans, et al., (Eds.),(1996),pp. 1-23.
Berns, K. I., “Parvovirus Replication”,Microbiological Reviews, 54 (3), (Sep. 1990),pp. 316-329.
Clark, K. R., et al., “Recombinant Adeno-Associated Viral Vectors Mediate Long-Term Transgene Expression in Muscle”,Human Gene Therapy, 8, (Apr. 10, 1997),pp. 659-669.
Conrad, C. K., et al., “Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung”,Gene Therapy, 3, (1996),pp. 658-668.
Duan, D , et al., “Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue”,Journal of Virology, 72 (11), (1998),pp. 8568-8577.
Duan, Dongsheng , et al., “Dynamin is required for recombinant adeno-associated virus type 2 infection”,J of Virology, vol. 73, No. 12, XP002154342, (Dec. 1999),10371-10376.
Duan, Dongsheng , et al., “Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus”,Journal of Clinical Investigation, vol. 105, No. 11, (Jun. 2000),1573-1587.
Duan, D. , “Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway Epithelia”,Human Gene Therapy, 9, (Dec. 10, 1998),pp. 2761-2776.
Duan, D , et al., “Response to “Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway Epithelia””,Human Gene Therapy, 10, (1999),pp. 1553-1557.
Fisher-Adams, G. , et al., “Integration of Adeno-Associated Virus Vectors in CD34+ Human Hematopoietic Progenitor Cells After Transduction”,Blood, 88 (2), (Jul. 15, 1996),pp. 492-504.
Flotte, T. R., et al., “Adeno-Associated Virus Vector Gene Expression Occurs in Nondividing Cells in the Absence of Vector DNA Integration”,American Journal of Respiratory Cell and Molecular Biology, 11, (1994),pp. 517-521.
Halbert, C. L., “Transduction by Adeno-Associated Virus Vectors in the Rabbit Airway: Efficiency, Persistence, and Readministration”,Journal of Virology, 71 (8), (Aug. 1997),pp. 5932-5941.
Kaplitt, M. G., et al., “Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain”,Nature Genetics, 8, (Oct. 1994),pp. 148-154.
Kearns, W. G., et al., “Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fachion in an immortalized epithelial cell line”,Gene Therapy, 3, (1996),pp. 748-755.
Kessler, P. D., et al., “Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein”,PNAS, 93, (Nov. 1996),pp. 14082-14087.
Kotin, R. M., et al., “Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination”,The EMBO Journal, 11
Duan Dongsheng
Engelhardt John F.
Yan Ziying
Blumel Benjamin P.
Campell Bruce R.
Schwegman Lundberg Woessner & Kluth P.A.
University of Iowa Research Foundation
LandOfFree
Adeno-associated virus vectors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adeno-associated virus vectors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated virus vectors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3791693